PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Nov-2021 AlivaMab Discovery Services Expands Discovery Agreement with IGM Biosciences Businesswire
01-Nov-2021 Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021 Businesswire
01-Nov-2021 Alzheon to Present New Data from Ongoing Phase 2 Biomarker Trial of ALZ-801 Oral Tablet at Clinical Trials in Alzheimer’s Disease (CTAD) Conference Businesswire
01-Nov-2021 武田宣佈收購自有股份 Businesswire
01-Nov-2021 武田宣布收购自有股份 Businesswire
01-Nov-2021 Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - ResearchAndMarkets.com Businesswire
01-Nov-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Nov-2021 SanBio Announces Publication Comparing Outcome Measures for Persons With Chronic Traumatic Brain Injury in Expert Review of Neurotherapeutics Businesswire
01-Nov-2021 Phase 3 Data of mdc-IRM, First Product Based on MedinCell’s Technology, Shows Significant Improvements in Patients With Schizophrenia Businesswire
31-Oct-2021 New Research for KEYTRUDA® (pembrolizumab) at Society for Melanoma Research (SMR) 2021 Congress Reinforces Merck’s Commitment to Patients With Melanoma Across Stages of Disease Businesswire
31-Oct-2021 Moderna Provides Update on Timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for Adolescents Businesswire
31-Oct-2021 Takeda entrega sólidos resultados no primeiro semestre do ano fiscal de 2021; ritmo de crescimento adicional esperado até o final do ano fiscal impulsionado por 14 marcas globais Businesswire
30-Oct-2021 New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to Impending Relapse Compared to Placebo in Patients with Schizophrenia Businesswire
30-Oct-2021 ALERT: BioMarin Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – BMRN Businesswire
30-Oct-2021 Takeda logra sólidos resultados en el primer semestre del año fiscal 2021; se espera un empuje mayor de crecimiento al final del año fiscal con el impulso de 14 marcas globales Businesswire
30-Oct-2021 Acticor Biotech is the laureate of the Prix Galien Medstartup award in the category “BEST COLLABORATION IN THE PHARMACEUTICAL OR BIOTECHNOLOGY INDUSTRY” Businesswire
30-Oct-2021 Takeda enregistre de solides résultats au 1er semestre de l’exercice 2021, une poursuite de la dynamique de croissance étant également prévue d’ici la fin de l’exercice, tirée par ses 14 marques mondiales Businesswire
30-Oct-2021 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CareDx, Inc. (CDNA) on Behalf of Investors Businesswire
29-Oct-2021 Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years Businesswire
29-Oct-2021 Steel Connect Reports Fourth Quarter Financial Results Businesswire